On April 1, 2019 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, reported that the Company will present at the following upcoming investor conferences (Press release, Scynexis, APR 1, 2019, View Source [SID1234534833]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The H.C. Wainwright Global Life Sciences Conference at the Grosvenor House A JW Marriott Hotel in London on Monday, April 8, 2019 at 4:50 p.m. GMT.
The 18th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York City on Wednesday, April 10, 2019 at 10:40 a.m. ET.
Live webcasts of the presentations will be available on the Investors section of the Company’s website: www.scynexis.com. Replays of the presentations will be available approximately two hours after each event and will be available for two weeks following each presentation.